Freenome and Biognosys Announce Collaboration to Improve Early-Cancer Detection and Treatment
– AI genomics company Freenome announces partnership with leading proteomics company Biognosys to enhance its broad-signal approach to early-cancer detection and precision oncology.
By decoding cell-free (cf) biomarker patterns of once unthinkable complexity, Freenome’s artificial intelligence […]